Our Research Partners
Dr. Paul Yong - UBC
The Endometriosis and Pelvic Pain Laboratory will improve understanding, care and awareness of endometriosis through cutting-edge interdisciplinary research and knowledge translation. We envision a world where people with endometriosis receive a timely diagnosis and personalized, effective treatment.
Dr. Aline Talhouk - UBC
The Uterine Health Research Lab is committed to research that pertains to health during and after the menopausal transition. Our team uses digital health, data science and artificial intelligence to propose strategies for monitoring and tracking health associated with reproductive aging. Our work spans several aspects of health including symptoms of abnormal bleeding, risk factors associated with malignancies, and optimal lifestyle for cancer prevention and to optimize healthy aging.
Dr. Hui Shen - Van Andel Institute
The Shen Laboratory focuses on the epigenome and its interaction with the genome in various diseases, with a specific emphasis on female cancers and cross-cancer comparisons. The Shen team uses bioinformatics as a tool to understand the etiology, cell of origin, and epigenetic mechanisms of various diseases and to devise better approaches for cancer prevention, detection, therapy, and monitoring. Team members have extensive experience with genome-scale DNA methylation profiles in primary human samples and have made major contributions to epigenetic analysis within The Cancer Genome Atlas (TCGA).
Dr. Kate Lawrenson - UT Health San Antonio
The Lawrenson Laboratory research program focuses on two gynecologic diseases—one rare (ovarian cancer) and one common (endometriosis). Both are unified by shared unmet clinical needs—a need for new biomarkers to aid in diagnosis and a need for new targeted therapeutics to expand options for precision medicine. The Lawrenson Laboratory focuses on studying the features and causes of disrupted gene regulation in these two diseases, and translational opportunities stemming from these insights. We rapidly integrate new next-generation sequence technologies to map genomic, transcriptomic and epigenomic features of normal and diseased tissues to create a holistic picture of gene dysregulation during disease development. Our studies are inspired and supported by our collaborations with clinical faculty within OB/GYN.
Dr. Martin Köbel
Dr. Martin Köbel - University of Calgary
Dr. Martin Köbel's primary research goal is application oriented refined biomarker based classification of ovarian and endometrial carcinomas, leading to stratified patient management based on reproducible molecular markers.
Dr. Stefan Kommoss
Dr. Stefan Kommoss - University of Tübingen
and Diakonie-Klinikum Schwäbisch Hall
Dr. Basile Tessier Cloutier
Dr. Basile Tessier Cloutier - McGill University
Dr. Mark Carey Lab
Dr. Mark Carey - UBC
Dr. Mark Carey's Lab concentrates their efforts in the laboratory on low-grade serous carcinoma.
Dr. Gillian E. Hanley - UBC
Dr. Hanley combines her substantive interest in women’s health with her training in economics, health services research and epidemiology to answer questions related to gynecologic cancer, primarily ovarian cancer prevention and survivorship, as well as healthy reproduction and pregnancy.
Dr. Brad Nelson - BC Cancer, Deeley Research Centre
The Nelson lab studies the immune response to cancer with the goal of developing immune-based strategies to prevent, detect and treat cancer.
Genomics of Reproductive Disorder Lab
Dr. Grant Montgomery - University of Queensland
Our group studies the role of genetic and environmental factors and their contribution to reproductive disorders to understand disease biology and translate knowledge gained for better clinical outcomes. We study disease populations using genetics and use advanced genomics methods in tissue samples and cell-based models, to discover the changes in cellular functions leading to disease. A major focus of our research is studies on endometriosis and related disorders.
Dr. Kylie Gorringe
Peter MacCallum Cancer Center
Dr. David Bowtell Lab
Dr. David Bowtell - Peter MacCallum Cancer Center
The David Bowtell lab team has a major focus on the genetic information (DNA) and immune characterization of ovarian cancer, seeking to understand the biology of treatment response and resistance and to translate these findings into new and more efficient treatment approaches.